Gendoo Deena M A, Haibe-Kains Benjamin
Bioinformatics and Computational Genomics Laboratory, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario Canada ; Department of Medical Biophysics, University of Toronto, Toronto, Ontario Canada.
Bioinformatics and Computational Genomics Laboratory, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario Canada ; Department of Medical Biophysics, University of Toronto, Toronto, Ontario Canada ; Department of Computer Science, University of Toronto, Toronto, Ontario Canada.
Source Code Biol Med. 2016 Apr 11;11:6. doi: 10.1186/s13029-016-0053-y. eCollection 2016.
Medulloblastoma (MB) is a highly malignant and heterogeneous brain tumour that is the most common cause of cancer-related deaths in children. Increasing availability of genomic data over the last decade had resulted in improvement of human subtype classification methods, and the parallel development of MB mouse models towards identification of subtype-specific disease origins and signaling pathways. Despite these advances, MB classification schemes remained inadequate for personalized prediction of MB subtypes for individual patient samples and across model systems. To address this issue, we developed the Medullo-Model to Subtypes ( MM2S ) classifier, a new method enabling classification of individual gene expression profiles from MB samples (patient samples, mouse models, and cell lines) against well-established molecular subtypes [Genomics 106:96-106, 2015]. We demonstrated the accuracy and flexibility of MM2S in the largest meta-analysis of human patients and mouse models to date. Here, we present a new functional package that provides an easy-to-use and fully documented implementation of the MM2S method, with additional functionalities that allow users to obtain graphical and tabular summaries of MB subtype predictions for single samples and across sample replicates. The flexibility of the MM2S package promotes incorporation of MB predictions into large Medulloblastoma-driven analysis pipelines, making this tool suitable for use by researchers.
The MM2S package is applied in two case studies involving human primary patient samples, as well as sample replicates of the GTML mouse model. We highlight functions that are of use for species-specific MB classification, across individual samples and sample replicates. We emphasize on the range of functions that can be used to derive both singular and meta-centric views of MB predictions, across samples and across MB subtypes.
Our MM2S package can be used to generate predictions without having to rely on an external web server or additional sources. Our open-source package facilitates and extends the MM2S algorithm in diverse computational and bioinformatics contexts. The package is available on CRAN, at the following URL: https://cran.r-project.org/web/packages/MM2S/, as well as on Github at the following URLs: https://github.com/DGendoo and https://github.com/bhklab.
髓母细胞瘤(MB)是一种高度恶性且异质性的脑肿瘤,是儿童癌症相关死亡的最常见原因。在过去十年中,基因组数据的可用性不断提高,这使得人类亚型分类方法得到改进,同时也推动了MB小鼠模型的同步发展,以确定亚型特异性疾病起源和信号通路。尽管取得了这些进展,但MB分类方案在针对个体患者样本以及跨模型系统进行MB亚型的个性化预测方面仍然不够完善。为了解决这个问题,我们开发了髓母细胞瘤亚型模型(MM2S)分类器,这是一种新方法,能够根据已确立的分子亚型对MB样本(患者样本、小鼠模型和细胞系)的个体基因表达谱进行分类[《基因组学》106:96 - 106,2015年]。我们在迄今为止最大规模的人类患者和小鼠模型荟萃分析中证明了MM2S的准确性和灵活性。在此,我们展示了一个新的功能包,它提供了MM2S方法的易于使用且文档完备的实现方式,还具备额外功能,允许用户获取单个样本及跨样本重复的MB亚型预测的图形和表格汇总。MM2S包的灵活性促进了将MB预测纳入大型髓母细胞瘤驱动的分析流程,使该工具适合研究人员使用。
MM2S包应用于两个案例研究,涉及人类原发性患者样本以及GTML小鼠模型的样本重复。我们重点介绍了在特定物种的MB分类中,针对单个样本和样本重复所使用的功能。我们强调了一系列可用于得出MB预测的单一和中心观点的功能,涵盖样本和MB亚型。
我们的MM2S包可用于生成预测,而无需依赖外部网络服务器或其他来源。我们的开源包在各种计算和生物信息学环境中促进并扩展了MM2S算法。该包可在CRAN上获取,网址如下:https://cran.r-project.org/web/packages/MM2S/,也可在Github上获取,网址如下:https://github.com/DGendoo和https://github.com/bhklab。